Global Hypodermic Needles Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Hypodermic Needles market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Hypodermic Needles market."
Hypodermic needles are hollow needles with sharp tip attached with syringes to inject or extract fluids from the body. 
Increasing prevalence of chronic diseases and technological advancements in hypodermic needle-based drug delivery are some of the major growth drivers of the global hypodermic needles market. According to an article published by the National Center for Biotechnology Information (NCBI), diabetes affected 285 million people worldwide in 2010 and the number is likely to reach 439 million by 2030. Increasing prevalence of diabetes has resulted in a significant rise in demand for hypodermic and insulin syringes.
However, high risk of infections associated with administration of drug delivery throughhypodermic needles restrains growth of this market. In addition, increased risk of needle stick injuries and availability of alternatives also restrain growth of the global hypodermic needles market. Rapid product launches and increasing mergers and acquisitions between manufacturing companies and government organizations are some of the recent trends in the global hypodermic needles market.

The global Hypodermic Needles market is valued at 2940 million US$ in 2018 is expected to reach 4720 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2019-2025.
This report focuses on Hypodermic Needles volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypodermic Needles market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    BD
    Medtronic
    Retractable Technologies
    Terumo Medical Corporation
    Smiths Medical
    ...

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Safety Needle
    Non-Safety Needle

Segment by Application
    Hospitals
    ASCs
    Homecare